ApconiX is delighted to welcome Dr Karen Jones who joins us from AstraZeneca. Karen, a talented electrophysiologist, will work with Dr Michael Morton to ensure the laboratory continues to provide an outstanding service as the demand for ion channel and cardiovascular safety screening increases.
Karen graduated from the University of Liverpool with a degree in Pharmacology. After researching the basis for naphthoquinone and biguanide synergy, Karen gained her PhD from the University of Liverpool. Karen worked at Astra Zeneca for some 14 years, most recently as project lead for multiple high throughput screening campaigns supporting projects in a range of disease areas including Neuroscience, Oncology, Cardiovascular and Metabolic disease.
Mike couldn’t be more pleased with the new member of the team, “In addition to her electrophysiology background, Karen brings Big Pharma expertise in high throughput screening and Genedata to ApconiX that adds to our future capability”.
“Experienced, flexible scientists are at the heart of the service we provide to our customers as we continue to shape and grow the European Centre of Excellence for preclinical cardiovascular electrophysiology.”